title: Tenecteplase: a promising new fibrinolytic agent.
abstract: Acute coronary syndrome can mean anything from unstable angina to acute myocardial infarction (MI) with ST-segment elevation. Tenecteplase, a new fibrinolytic agent used to treat ST-segment elevation acute MI, has some advantages over other fibrinolytic agents. This article describes tenecteplase's actions, indications, contraindications, and use.
authors.affiliation: United States Air Force, Keesler Air Force Base, Mississippi, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: De Jong
authors.forename: W
authors.initials: W
authors.lastname: Sabadie-Garretson
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000451:nursing; D016903:Drug Monitoring; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077785:Tenecteplase; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase